Inventor · disambiguated record
Annie Shin
Also filed as: SHIN ANNIE
6 granted patents·6 pending applications·0 citations·filing 2018–2025
67Inventor score
Top patents by PatentIndex Score
12 records- 0181US12290558B2SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogensIMMUNITYBIO INC·Filed 2023·Granted May 6, 2025·0 cites·11 claims
- 0278US12247086B2Enhanced immunogenicity for GPI-anchored antigensNANTBIO INC·Filed 2023·Granted Mar 11, 2025·0 cites·18 claims
- 0369US2025235530A1Anti COVID-19 Therapies targeting nucleocapsid and spike proteinsIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 0468US11857620B2Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirusIMMUNITYBIO INC·Filed 2021·Granted Jan 2, 2024·0 cites·11 claims
- 0568US11773187B2Enhanced immunogenicity for GPI-anchored antigensNANTBIO INC·Filed 2019·Granted Oct 3, 2023·0 cites·6 claims
- 0668US2023039169A1Modified EC7 Cells Having Low Toxicity to Viral Production PayloadsNANTBIO INC·Filed 2022·Application pending·0 cites
- 0765US2025179217A1Enhanced Immunogenicity For GPI-anchored AntigensNANTBIO INC·Filed 2025·Application pending·0 cites
- 0858US11485957B2Modified EC7 cells having low toxicity to viral production payloadsNANTBIO INC·Filed 2018·Granted Nov 1, 2022·0 cites·8 claims
- 0956US12448638B2Enzyme based system for production of messenger RNA with increased transfection efficiencyIMMUNITYBIO INC·Filed 2022·Granted Oct 21, 2025·0 cites·7 claims
- 1051US2021284713A1Anti covid-19 therapies using cd40 ligand fusion proteinIMMUNITYBIO INC·Filed 2020·Application pending·0 cites
- 1146US2020283531A1Lipid-Based Antigens and T-Cell Receptors on NK CellsNANTCELL INC·Filed 2018·Application pending·0 cites
- 1241US2020282037A1Bacterial vaccineNANTBIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annie Shin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →